YSELTY

This brand name is authorized in Austria, Croatia, France, Italy, Lithuania.

Active ingredients

The drug YSELTY contains one active pharmaceutical ingredient (API):

1	Linzagolix choline UNII VHS6SC660Q - LINZAGOLIX CHOLINE
	Linzagolix is a selective, non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist that inhibits endogenous GnRH signalling by binding competitively to GnRH receptors in the pituitary gland, thereby modulating the hypothalamic-pituitary-gonadal axis.
	Read more about Linzagolix

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
YSELTY Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H01CC04		H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01C Hypothalamic hormones → H01CC Anti-gonadotropin-releasing hormones
Discover more medicines within H01CC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FR	Base de données publique des médicaments	62713042, 66783216
IT	Agenzia del Farmaco	050222013, 050222025
LT	Valstybinė vaistų kontrolės tarnyba	1094959, 1094960